FrederickMHechtMD
Internal Medicine • San Francisco, CAProfessor, Medicine, University of California, San Francisco, School of Medicine
Are you Dr. Hecht?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
995 Potrero Avenue
Bldg 80 Ward 84
San Francisco, CA 94110Phone+1 415-476-4082Fax+1 415-476-6953
Summary
- Dr. Frederick Hecht, MD is a board certified internist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with UCSF Medical Center and is a Professor at University of California.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1986 - 1989
State University of New York Downstate Medical Center College of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1991 - 2024- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression Start of enrollment: 2004 Jul 01
- Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons Start of enrollment: 2009 Aug 01
Publications & Presentations
PubMed
- Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT).Ashley E Mason, Anoushka Chowdhary, Wendy Hartogensis, Chelsea J Siwik, Osnat Lupesko-Persky
International Journal of Hyperthermia. 2024-01-01 - 39 citationsItraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.Frederick Hecht, Joseph Wheat, Ann H. Korzun, Richard Hafner, Kenneth J. Skahan
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1997-10-01 - 421 citationsTryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.David Favre, Jeff E. Mold, Peter W. Hunt, Bittoo Kanwar, P'ng Loke
Science Translational Medicine. 2010-05-19
Press Mentions
Smart Ring May Flag Early Illnesses, UCSF-UCSD Study ShowsDecember 14th, 2020
Untimely Tip - Helmets for Ice Skating KidsNovember 22nd, 2019
The UCSF Guide to Healthy and Happy EatingJuly 2nd, 2019- Join now to see all
Grant Support
- Clinical CoreNational Institute Of Allergy And Infectious Diseases2011
- Training Researchers In Clinical Integrative Medicine (TRIM)National Center For Complementary &Alternative Medicine2009–2011
- Metabolic And Immunologic Effects Of MeditationNational Center For Complementary &Alternative Medicine2008–2011
- Transmission And Persistence Of CTL And Drug Resistance MutationsNational Institute Of Allergy And Infectious Diseases2007–2011
- The Biology Of HIV TransmissionNational Institute Of Allergy And Infectious Diseases2007–2011
- Clinical CoreNational Institute Of Allergy And Infectious Diseases2007–2011
- Supplement - Clinical CoreNational Institute Of Allergy And Infectious Diseases2010
- Metabolic And Immunologic Effects Of Meditation - Cell Aging SupplementNational Center For Complementary &Alternative Medicine2009
- NK Cell Responses In HIV InfectionNational Institute Of Allergy And Infectious Diseases2005–2009
- Mbsr, Stress Arousal And Immune Response In Early HIVNational Center For Complementary &Alternative Medicine2008
- Project 1 - A Clinical Trial Of Mindfulness Based Stress Reduction In Early HIVNational Center For Complementary &Alternative Medicine2004–2008
- Administrative &Analysis CoreNational Institute Of Allergy And Infectious Diseases2007
- Yoga, HEALTH, And MeditationNational Center For Complementary &Alternative Medicine2003–2004
